Poket News

First anti-cancer drug from India enters Chinese markets

 

  • A breakthrough for the Indian pharmaceutical industry in China has been achieved as the first anti-cancer drug from India has entered the Chinese markets. 
  • Agreements have been signed between local Chinese companies and India’s Dr. Reddy’s Lab for the sale of Abirateron, the first anti-cancer drug from India in China. 
  • India’s Ambassador Vikram Misri announced this in a tweet.
  • There is a huge demand for cancer drugs in China as the mortality rate of cancer in China is high.